Showing results (181-190 of 235) with videos related to

Sort By:
Pageof 24
Genetic Epidemiology|September 25, 2015
Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) RiskErnest K Amankwah, Hui-Yi Lin, Jonathan P Tyrer, et al.
Nature Genetics|January 24, 2012
Genome-wide association analysis identifies three new breast cancer susceptibility lociMaya Ghoussaini, Olivia Fletcher, Kyriaki Michailidou, et al.
Breast Cancer Research : BCR|June 3, 2014
Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control studyNichola Johnson, Frank Dudbridge, Nick Orr, et al.
NPJ Genomic Medicine|November 20, 2025
Genome-wide association study of 398,238 women unveils seven loci associated with high-grade serous ovarian cancerDaniel R Barnes, Jonathan P Tyrer, Joe Dennis, et al.
Genome Medicine|January 26, 2023
Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestryStefanie H Mueller, Alvina G Lai, Maria Valkovskaya, et al.
American Journal of Human Genetics|June 19, 2021
Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer elementJoseph S Baxter, Nichola Johnson, Katarzyna Tomczyk, et al.
Nature Genetics|January 10, 2019
Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility lociFredrick R Schumacher, Ali Amin Al Olama, Sonja I Berndt, et al.
Nature Genetics|June 13, 2018
Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility lociFredrick R Schumacher, Ali Amin Al Olama, Sonja I Berndt, et al.
American Journal of Human Genetics|December 3, 2013
Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1Kerstin B Meyer, Martin O'Reilly, Kyriaki Michailidou, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 16, 2020
Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variantsDaniel R Barnes, Matti A Rookus, Lesley McGuffog, et al.
Pageof 24